Next-Generation Tablo Hemodialysis System Receives FDA Clearance, Second Quarter Launch Planned

Tablo becomes first dialysis system to clear FDA’s most rigorous cybersecurity standardsSAN JOSE, Calif., Jan. 27, 2026 ...
MassDevice

Outset Medical wins FDA nod for next-gen Tablo hemodialysis system

Outset Medical (Nasdaq: OM) announced today that it received FDA 510(k) clearance for its next-generation Tablo hemodialysis platform.
Investing.com South Africa

Outset Medical stock jumps after FDA clears next-gen Tablo platform

Investing.com -- Outset Medical Inc (NASDAQ:OM) stock jumped 9% in premarket trading Tuesday after the medical technology company announced FDA clearance for its next-generation Tablo dialysis ...
Business Wire

New Data Insights Unveiled at ASN Kidney Week 2023 Point to the Impact of the Tablo® Hemodialysis System on Equitable Kidney Care

SAN JOSE, Calif.--(BUSINESS WIRE)--Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company reducing the cost and complexity of dialysis with its Tablo® Hemodialysis System, today ...